Verified· 2 sources

Cellerys AG

Summary

About the company

The core activity of Cellerys AG is the development of therapies for the treatment of autoimmune diseases, particularly multiple sclerosis, through the application of immunotherapies and cell therapies. The company focuses on the development of EpiTCer-based therapies, which aim to modulate the immune response to autoreactive T-cells. Cellerys conducts clinical trials and collaborates with partners such as Novartis and TETEC to develop and market its therapies.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Cellerys AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Cellerys AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Cellerys AG in comparison

Industry comparisons are coming soon

Similar companies